SCHEMBL22198150

SCHEMBL22198150

C(=N/N=C/c1ccc(N2CCCCC2)cc1)\c1ccc(N2CCCCC2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.62
KDM4E B2RXH2 3/20 0.62
SMN1; SMN2 Q16637 3/20 0.62
TRIM24 O15164 1/20 0.59
TRIM33 Q9UPN9 1/20 0.59
FURIN P09958 1/20 0.58
MAPT P10636 6/20 0.50
PTGS2 P35354 3/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
RECQL P46063 2/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
USP2 O75604 1/20 0.50
TP53 P04637 1/20 0.50
POLB P06746 1/20 0.50
GAA P10253 1/20 0.50
THRB P10828 1/20 0.50
ALOX15 P16050 1/20 0.50
HTT P42858 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22198241 0.98 TRIM24 (0.61) ALDH1A1KDM4ESMN1; SMN2TRIM24TRIM33
SCHEMBL22198292 0.84 CA12 (0.49) ALDH1A1KDM4ESMN1; SMN2TRIM24TRIM33
SCHEMBL22198146 0.84 SLC2A1 (0.59) ALDH1A1KDM4ESMN1; SMN2TRIM24TRIM33
SCHEMBL13855689 0.84 ALDH1A1 (0.58) ALDH1A1KDM4ESMN1; SMN2TRIM24TRIM33
SCHEMBL13855691 0.84 ALDH1A1 (0.58) ALDH1A1KDM4ESMN1; SMN2TRIM24TRIM33
SCHEMBL11226301 0.82 TRIM24 (0.57) ALDH1A1KDM4ESMN1; SMN2TRIM24TRIM33
SCHEMBL20014003 0.82 TRIM24 (0.57) ALDH1A1KDM4ESMN1; SMN2TRIM24TRIM33
SCHEMBL11226294 0.82 TRIM24 (0.57) ALDH1A1KDM4ESMN1; SMN2TRIM24TRIM33
SCHEMBL22198154 0.82 ALDH1A1 (0.67) ALDH1A1KDM4ESMN1; SMN2FURINMAPT
SCHEMBL7718270 0.80 ALDH1A1 (0.69) ALDH1A1KDM4ESMN1; SMN2TRIM24TRIM33

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210393810-A1 DIHYDRAZONE COMPOUNDS HAVING HIGH AFFINITY TO A BETA PROTEIN AND TAU PROTEIN, DERIVATIVES THEREOF AND USE THEREOF HTA Co., Ltd. (CN) 2021-12-23 US disclosed
WO-2020140924-A1 DIHYDRAZONE COMPOUNDS HAVING HIGH AFFINITY TO AΒ PROTEIN AND TAU PROTEIN, DERIVATIVES THEREOF AND USE THEREOF 原子高科股份有限公司 2020-07-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210393810-A1 DIHYDRAZONE COMPOUNDS HAVING HIGH AFFINITY TO A BETA PROTEIN AND TAU PROTEIN, DERIVATIVES THEREOF AND USE THEREOF MAPT, APP, PSEN1 ALDH1A1 1343/4885KDM4E 4710/4885SMN1; SMN2 2538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.